Retrieve available abstracts of 37 articles: HTML format
Single Articles
May 2025
PAKUWAL E, Tan JL, Page AJ, Stringer AM, et al A systematic review and meta-analysis on the efficacy of fecal microbiome
transplantation in patients with severe alcohol-associated hepatitis.
Eur J Gastroenterol Hepatol. 2025 May 8. doi: 10.1097/MEG.0000000000003003. PubMedAbstract available
HABIBI MA, Aghayee F, Mirjani MS, Karimifar MR, et al The safety and efficacy of rituximab in autoimmune hepatitis: a systematic review
and quality assessment.
Eur J Gastroenterol Hepatol. 2025 May 6. doi: 10.1097/MEG.0000000000002981. PubMedAbstract available
CHEN J, Liu X, Guan C, Peng Y, et al Sterile systemic inflammation reaction associated with 90-day mortality in
patients with HBV-related acute-on-chronic liver failure.
Eur J Gastroenterol Hepatol. 2025;37:644-651. PubMedAbstract available
March 2025
GARCIA-HEROLA A, Sanchez-Reyes MS, Gomez-Escolar L, Llobregat L, et al Efficiency of opportunistic population screening in a gastrointestinal endoscopy
unit as a hepatitis C elimination strategy.
Eur J Gastroenterol Hepatol. 2025 Mar 26. doi: 10.1097/MEG.0000000000002973. PubMedAbstract available
LIU T, Gu J A cross-sectional study investigating knowledge, attitudes, and practices of the
general population regarding early diagnosis and treatment of hepatitis.
Eur J Gastroenterol Hepatol. 2025 Mar 4. doi: 10.1097/MEG.0000000000002957. PubMedAbstract available
February 2025
HE Q, Chen Z, Deng Y, Mao C, et al Plasma microRNA-30a expression in patients with chronic hepatitis B and its
application value in the assessment of the severity of liver fibrosis.
Eur J Gastroenterol Hepatol. 2025 Feb 18. doi: 10.1097/MEG.0000000000002918. PubMedAbstract available
LIU T, Shi Y, Wu J, Qin L, et al Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic
hepatitis B patients.
Eur J Gastroenterol Hepatol. 2025 Feb 11. doi: 10.1097/MEG.0000000000002946. PubMedAbstract available
DOS SANTOS DM, Penteado JO, Nader MM, Basso RP, et al Analysis of noninvasive methods in chronic hepatitis/human immunodeficiency virus
mono- and co-infected patients with advanced fibrosis.
Eur J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1097/MEG.0000000000002936. PubMedAbstract available
January 2025
EL-KASSAS M, Barakat EMF, Shousha HI, Kohla M, et al Characteristics and survival of patients with viral versus nonviral associated
hepatocellular carcinoma: a multicenter cohort study.
Eur J Gastroenterol Hepatol. 2025;37:83-93. PubMedAbstract available
ALHALABI MM, Almokdad R The incidence of hepatitis B reactivation in patients receiving ustekinumab: a
systematic review and proportional meta-analysis.
Eur J Gastroenterol Hepatol. 2025;37:1-9. PubMedAbstract available
December 2024
The Primary Cause of Markedly Elevated Aminotransferases in Hospitalized Patients
with Cirrhosis in Ischemic Hepatitis: Erratum.
Eur J Gastroenterol Hepatol. 2024;36:1472. PubMed
November 2024
ZHANG J, Lin Y, Zhu Y Recompensation features and prognosis in hepatitis B virus-related
acute-on-chronic liver failure patients.
Eur J Gastroenterol Hepatol. 2024 Nov 14. doi: 10.1097/MEG.0000000000002891. PubMedAbstract available
ZHANG S, Zhou T, Wu M, Xiong X, et al Sarcopenia is associated with new-onset acute biliary infection within 1 year in
patients with hepatitis B virus-related decompensated cirrhosis.
Eur J Gastroenterol Hepatol. 2024 Nov 8. doi: 10.1097/MEG.0000000000002875. PubMedAbstract available
ALLAM J, Ibrahim A, Rockey DC The primary cause of markedly elevated aminotransferases in hospitalized patients
with cirrhosis in ischemic hepatitis.
Eur J Gastroenterol Hepatol. 2024;36:1346-1351. PubMedAbstract available
October 2024
GIORGIO M, Ramirez Ladino KA, Lopez G, Sosa Rojas M, et al Frequency of hepatitis D virus with different hepatitis B virus serological
markers and coinfections in hospital patients from Argentina: synchronous testing
of anti-HDV antibodies and HDV RNA.
Eur J Gastroenterol Hepatol. 2024 Oct 8. doi: 10.1097/MEG.0000000000002857. PubMedAbstract available
September 2024
ALLAM J, Ibrahim A, Rockey DC The primary cause of markedly elevated aminotransferases in hospitalized patients
with cirrhosis in ischemic hepatitis.
Eur J Gastroenterol Hepatol. 2024 Sep 23. doi: 10.1097/MEG.0000000000002855. PubMedAbstract available
July 2024
ZHANG Y, Lin X, Wu H, Chen J, et al Systematic review with network meta-analysis: sustained hepatitis B surface
antigen clearance after pegylated interferon cessation.
Eur J Gastroenterol Hepatol. 2024 Jul 22. doi: 10.1097/MEG.0000000000002823. PubMedAbstract available
DANIELSSON O, Vesterinen T, Arola J, Aberg F, et al Coexistence of metabolic-associated fatty liver disease and autoimmune or toxic
liver disease.
Eur J Gastroenterol Hepatol. 2024;36:961-969. PubMedAbstract available
June 2024
WANG FC, Dong Y, Xu ZQ, Gao YJ, et al Characteristics analysis of hepatitis B core-related antigen in children with
hepatitis B e antigen-positive chronic viral hepatitis B infection.
Eur J Gastroenterol Hepatol. 2024 Jun 28. doi: 10.1097/MEG.0000000000002812. PubMedAbstract available
LIN CY, Sun WC, Lu CM, Chen WC, et al Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis
B patients with severe acute exacerbation.
Eur J Gastroenterol Hepatol. 2024 Jun 26. doi: 10.1097/MEG.0000000000002709. PubMedAbstract available
XU J, Tan L, Jiang N, Li F, et al Assessment of nomogram model for the prediction of esophageal variceal hemorrhage
in hepatitis B-induced hepatic cirrhosis.
Eur J Gastroenterol Hepatol. 2024;36:758-765. PubMedAbstract available
CADRANEL JD, Zougmore HT, Efole JN, Hanslik B, et al Hepatitis B Delta: assessment of the knowledge and practices of
hepato-gastroenterologists practicing in non-academic settings in France.
Eur J Gastroenterol Hepatol. 2024;36:735-741. PubMedAbstract available
May 2024
VUKOVIC MN, Jaksic M, Stojanovic D, Smolovic B, et al Time trends in liver cancer mortality rates in Montenegro from 1990 to 2018.
Eur J Gastroenterol Hepatol. 2024;36:622-627. PubMedAbstract available
PEPPAS S, Doumas S, Suvarnakar A, Chou J, et al Clinical outcomes with metformin use in diabetic patients with compensated
cirrhosis: a systematic review and meta-analysis.
Eur J Gastroenterol Hepatol. 2024;36:674-682. PubMedAbstract available
April 2024
MACIEL AMA, Ferraz MLCG, Perez RM, Brandao-Mello CE, et al Renal dysfunction during treatment of chronic hepatitis B with tenofovir
disoproxyl fumarate and associated risk factors.
Eur J Gastroenterol Hepatol. 2024;36:482-488. PubMedAbstract available
ARSLAN E, Yildiz Y, Karasahin O, Demir Y, et al Evaluation of chronic hepatitis B patients who voluntarily discontinued oral
antiviral therapy: is there an answer to the controversial topic?
Eur J Gastroenterol Hepatol. 2024;36:438-444. PubMedAbstract available
KOROGLU M, Ayvaz MA, Bakan SB, Sirin A, et al Can quantitative surface antigen levels and systemic immune-inflammation index be
predictive as a new indicator for the initiation of treatment in chronic
hepatitis b?
Eur J Gastroenterol Hepatol. 2024;36:489-497. PubMedAbstract available
March 2024
HATOUM S, Rockey DC Long-term outcomes of patients with autoimmune hepatitis induced cirrhosis after
immunosuppressive treatment.
Eur J Gastroenterol Hepatol. 2024 Mar 28. doi: 10.1097/MEG.0000000000002714. PubMedAbstract available
YUKSEKYAYLA O, Kina N, Ulaba A, Emin Ergun M, et al The frequency and clinical significance of antibodies to soluble liver
antigen/liver pancreas in autoimmune hepatitis: a prospective single-center
study.
Eur J Gastroenterol Hepatol. 2024 Mar 4. doi: 10.1097/MEG.0000000000002747. PubMedAbstract available
LAI X, Chen H, Dong X, Zhou G, et al AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients
with chronic HBV infection.
Eur J Gastroenterol Hepatol. 2024;36:338-344. PubMedAbstract available
ARYAN M, Qian S, Chen Z, Louissaint J, et al Patients with early-stage alcohol-associated liver disease are at increased risk
of hospital readmission and death.
Eur J Gastroenterol Hepatol. 2024;36:318-325. PubMedAbstract available
February 2024
ABDULLAYEVA M, Celik M, Kuruuzum Z The performance of hepatitis B surface antigen quantification as a noninvasive
biomarker predicting liver injury and serum hepatitis B virus DNA level.
Eur J Gastroenterol Hepatol. 2024;36:245-249. PubMedAbstract available
January 2024
BRUNNER N, Grischott T, Bruggmann P Late presentation for hepatitis C treatment: prevalence and risk factors in the
Swiss Hepatitis C Cohort.
Eur J Gastroenterol Hepatol. 2024 Jan 22. doi: 10.1097/MEG.0000000000002705. PubMedAbstract available
November 2023
WANG X, Liu H, Wang P, Wang Y, et al A nomogram for analyzing risk factors of poor treatment response in patients with
autoimmune hepatitis.
Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002661. PubMedAbstract available
UZEL A, Ebik B, Bucaktepe GE, Yolacan R, et al Do oral antiviral drugs used in the treatment of chronic hepatitis B cause
erectile dysfunction?
Eur J Gastroenterol Hepatol. 2023 Nov 7. doi: 10.1097/MEG.0000000000002672. PubMedAbstract available
TSAI PS, Cheng YM, Wang CC, Kao JH, et al The impact of concomitant hepatitis C virus infection on liver and cardiovascular
risks in patients with metabolic-associated fatty liver disease.
Eur J Gastroenterol Hepatol. 2023;35:1278-1283. PubMedAbstract available
October 2023
OZDEN I, Kinaci E, Ocak I, Colak M, et al Successful results of early nucleos(t)ide analogue treatment for liver
transplantation candidates with severe acute hepatitis B infection.
Eur J Gastroenterol Hepatol. 2023 Oct 6. doi: 10.1097/MEG.0000000000002655. PubMedAbstract available